Search

Search Constraints

You searched for: Author/Creator Lalezari, F.

Search Results

1. 36MO Location and size of metastasectomy in melanoma patients treated with tumor-infiltrating lymphocytes (TIL) in relation to clinical outcome. (December 2022)

2. 8P Phenotypic characterization of infused tumor-infiltrating lymphocytes (TIL) correlates with response to adoptive cellular therapy (ACT) in patients with metastatic melanoma (MM). (December 2022)

3. A framework for systematic clinical evaluation of technical innovations in lung cancer patients treated on the MR-linac (MRL). (January 2019)

4. EP-1346 A framework for systematic clinical evaluation of the MR-linac for treatment of lung cancer patients. (April 2019)

5. Gross tumour volume (GTV) delineation on magnetic resonance imaging (MRI), for stage III lung cancer: consensus recommendations needed to ensure contouring consistency. (January 2019)

6. MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial. (September 2022)

7. OC-0609: The PET-boost trial: isotoxic homogeneous or FDG-directed dose escalation in stage II-III NSCLC. (November 2020)

8. OC-0692: Phase 1 study of olaparib as radiosensitizer for locally advanced non-small cell lung cancer. (November 2020)

10. The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases. Issue 3 (March 2019)